ligands acting on targets

(R)-3-Carboxy-4-hydroxyphenylglycine.

(R)-3-Carboxy-4-hydroxyphenylglycine.

(R)-4-((8-Cyclopentyl-5-methyl-6-oxo-7-propyl-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide.

(R)-4-((8-Cyclopentyl-5-methyl-6-oxo-7-propyl-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide.

(R)-4-Bromo Phenylephrine Hydrochloride.

(R)-4-Carboxyphenylglycine is a moderately potent NMDA receptor antagonist.

(R)-4-Carboxyphenylglycine is a moderately potent NMDA receptor antagonist.

(R)-4-Chlorokynurenine.

(R)-5,7-Dimethoxyflavanone shows potent antimutagenic activity against MeIQ mutagenesis in Ames test using the S. typhimurium TA100 and TA98 strains. And (R)-5,7-Dimethoxyflavanone significantly and dose-dependently inhibits the inflammatory

(R)-5,7-Dimethoxyflavanone shows potent antimutagenic activity against MeIQ mutagenesis in Ames test using the S. typhimurium TA100 and TA98 strains. And (R)-5,7-Dimethoxyflavanone significantly and dose-dependently inhibits the inflammatory

(R)-5-Bromo Naproxen.

(R)-5-Bromo-3-(N-methylpyrrolidin-2-ylmethyl-d5)-1H-indole.